176 related articles for article (PubMed ID: 36724763)
1. Epithelial Barrier in the Nasal Mucosa, Related Risk Factors and Diseases.
Zhang R; Zhang L; Li P; Pang K; Liu H; Tian L
Int Arch Allergy Immunol; 2023; 184(5):481-501. PubMed ID: 36724763
[TBL] [Abstract][Full Text] [Related]
2. Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis.
Steelant B; Wawrzyniak P; Martens K; Jonckheere AC; Pugin B; Schrijvers R; Bullens DM; Vanoirbeek JA; Krawczyk K; Dreher A; Akdis CA; Hellings PW
J Allergy Clin Immunol; 2019 Nov; 144(5):1242-1253.e7. PubMed ID: 31082457
[TBL] [Abstract][Full Text] [Related]
3. Barrier dysfunction in the nasal allergy.
Fukuoka A; Yoshimoto T
Allergol Int; 2018 Jan; 67(1):18-23. PubMed ID: 29150353
[TBL] [Abstract][Full Text] [Related]
4. Updated epithelial barrier dysfunction in chronic rhinosinusitis: Targeting pathophysiology and treatment response of tight junctions.
Huang ZQ; Liu J; Sun LY; Ong HH; Ye J; Xu Y; Wang DY
Allergy; 2024 May; 79(5):1146-1165. PubMed ID: 38372149
[TBL] [Abstract][Full Text] [Related]
5. Diesel exhaust particles exacerbate allergic rhinitis in mice by disrupting the nasal epithelial barrier.
Fukuoka A; Matsushita K; Morikawa T; Takano H; Yoshimoto T
Clin Exp Allergy; 2016 Jan; 46(1):142-52. PubMed ID: 26201369
[TBL] [Abstract][Full Text] [Related]
6. Epithelial physical barrier defects in chronic rhinosinusitis.
Jiao J; Wang C; Zhang L
Expert Rev Clin Immunol; 2019 Jun; 15(6):679-688. PubMed ID: 30925220
[TBL] [Abstract][Full Text] [Related]
7. The Role of Innate Immunity and Aeroallergens in Chronic Rhinosinusitis.
London NR; Tharakan A; Ramanathan M
Adv Otorhinolaryngol; 2016; 79():69-77. PubMed ID: 27466848
[TBL] [Abstract][Full Text] [Related]
8. Nasal Epithelial Barrier Integrity and Tight Junctions Disruption in Allergic Rhinitis: Overview and Pathogenic Insights.
Nur Husna SM; Tan HT; Md Shukri N; Mohd Ashari NS; Wong KK
Front Immunol; 2021; 12():663626. PubMed ID: 34093555
[TBL] [Abstract][Full Text] [Related]
9. Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis.
Steelant B; Seys SF; Van Gerven L; Van Woensel M; Farré R; Wawrzyniak P; Kortekaas Krohn I; Bullens DM; Talavera K; Raap U; Boon L; Akdis CA; Boeckxstaens G; Ceuppens JL; Hellings PW
J Allergy Clin Immunol; 2018 Mar; 141(3):951-963.e8. PubMed ID: 29074456
[TBL] [Abstract][Full Text] [Related]
10. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4.
Soyka MB; Wawrzyniak P; Eiwegger T; Holzmann D; Treis A; Wanke K; Kast JI; Akdis CA
J Allergy Clin Immunol; 2012 Nov; 130(5):1087-1096.e10. PubMed ID: 22840853
[TBL] [Abstract][Full Text] [Related]
11. Human cystatin SN is an endogenous protease inhibitor that prevents allergic rhinitis.
Fukuoka A; Matsushita K; Morikawa T; Adachi T; Yasuda K; Kiyonari H; Fujieda S; Yoshimoto T
J Allergy Clin Immunol; 2019 Mar; 143(3):1153-1162.e12. PubMed ID: 30012514
[TBL] [Abstract][Full Text] [Related]
12. MiR-29a-3p promotes nasal epithelial barrier dysfunction via direct targeting of CTNNB1-VCL module in allergic rhinitis.
Wang N; Li P; Liu J; Wang Z
Int Immunopharmacol; 2023 Jul; 120():110325. PubMed ID: 37262956
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of Basonuclin1 Is Associated with p63-Involved Epithelial Barrier Impairment and Type-2 Helper T-cell Inflammation in Chronic Rhinosinusitis with Nasal Polyps.
Gao Y; Li J; Jiao J; Li Y; Wang C; Zhang Y; Zhang L
Int Arch Allergy Immunol; 2021; 182(11):1046-1057. PubMed ID: 34148047
[TBL] [Abstract][Full Text] [Related]
14. Allergic rhinitis associated with nasal polyps and rhinosinusitis - histopathological and immunohistochemical study.
Iordache A; Balica NC; Horhat ID; Morar R; Tischer AA; Milcu AI; Salavat MC; Borugă VM; Niculescu B; Iovănescu G; Popa ZL
Rom J Morphol Embryol; 2022; 63(2):413-419. PubMed ID: 36374146
[TBL] [Abstract][Full Text] [Related]
15. Formation of papillary mucosa folds and enhancement of epithelial barrier in odontogenic sinusitis.
Zhang Y; Lan F; Li Y; Wang C; Zhang L
Int Forum Allergy Rhinol; 2019 Nov; 9(11):1281-1288. PubMed ID: 30620087
[TBL] [Abstract][Full Text] [Related]
16. Different effects of allergic rhinitis on nasal mucosa remodeling in chronic rhinosinusitis with and without nasal polyps.
Xiang R; Zhang QP; Zhang W; Kong YG; Tan L; Chen SM; Deng YQ; Tao ZZ; Xu Y
Eur Arch Otorhinolaryngol; 2019 Jan; 276(1):115-130. PubMed ID: 30446828
[TBL] [Abstract][Full Text] [Related]
17. Contemporary Pharmacotherapy for Allergic Rhinitis and Chronic Rhinosinusitis.
Ghadersohi S; Tan BK
Otolaryngol Clin North Am; 2017 Dec; 50(6):1135-1151. PubMed ID: 28964532
[TBL] [Abstract][Full Text] [Related]
18. Comparison of inflammatory cytokine release from nasal epithelial cells of non-atopic non-rhinitic, allergic rhinitic and polyp subjects and effects of diesel exhaust particles in vitro.
Ozturk AB; Bayraktar R; Gogebakan B; Mumbuc S; Bayram H
Allergol Immunopathol (Madr); 2017; 45(5):473-481. PubMed ID: 28259510
[TBL] [Abstract][Full Text] [Related]
19. The destruction of mucosal barriers, epithelial remodeling, and impaired mucociliary clearance: possible pathogenic mechanisms of Pseudomonas aeruginosa and Staphylococcus aureus in chronic rhinosinusitis.
Chegini Z; Noei M; Hemmati J; Arabestani MR; Shariati A
Cell Commun Signal; 2023 Oct; 21(1):306. PubMed ID: 37904180
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase activity is a novel target for epithelial barrier defects in patients with eosinophilic chronic rhinosinusitis with nasal polyps.
Duan S; Han X; Jiao J; Wang M; Li Y; Wang Y; Zhang L
Clin Exp Allergy; 2023 Apr; 53(4):443-454. PubMed ID: 36458367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
